Skip to Main Content

Author Details

Jonathan E Gable
Novartis Institute for Tropical Diseases
2008
14
10
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37384702Cyanotriazoles are selective topoisomerase II poisons that rapidly cure trypanosome infections.Science2023
35993839Discovery of Novel Quinoline-Based Proteasome Inhibitors for Human African Trypanosomiasis (HAT).J Med Chem2022
32101427An Artificial Intelligence Approach to Proactively Inspire Drug Discovery with Recommendations.J Med Chem2020
28759216Allosteric Inhibitors, Crystallography, and Comparative Analysis Reveal Network of Coordinated Movement across Human Herpesvirus Proteases.J Am Chem Soc2017
26822284Fragment-Based Protein-Protein Interaction Antagonists of a Viral Dimeric Protease.ChemMedChem2016
24977643Broad-spectrum allosteric inhibition of herpesvirus proteases.Biochemistry2014
25275644Current and potential treatments for ubiquitous but neglected herpesvirus infections.Chem Rev2014
23509259Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1.Proc Natl Acad Sci U S A2013
21723875Enzyme inhibition by allosteric capture of an inactive conformation.J Mol Biol2011
19817473Hydrogen bonding and solvent polarity markers in the uv resonance raman spectrum of tryptophan: application to membrane proteins.J Phys Chem B2009
25593677Toxins and antimicrobial peptides: Interactions with membranes.Proc SPIE Int Soc Opt Eng2009
19894716Fluorescence and UV resonance Raman study of peptide-vesicle interactions of human cathelicidin LL-37 and its F6W and F17W mutants.Biochemistry2009
18991402Effects of tryptophan microenvironment, soluble domain, and vesicle size on the thermodynamics of membrane protein folding: lessons from the transmembrane protein OmpA.Biochemistry2008
19756254Förster Resonance Energy Transfer and Conformational Stability of Proteins: An Advanced Biophysical Module for Physical Chemistry Students.J Chem Educ2008
  • 1 - 14 of 14

Recommended Authors

Arthur O Zalevsky
University of California san francisco
Career Start Year 2015
Number of shared co-authors 2
Sakshi Tomar
J. David Gladstone Institutes
Career Start Year 2009
Number of shared co-authors 0
David A Jacques
University of New South Wales
Career Start Year 2007
Number of shared co-authors 1
Sayantan Bose
Bose Institute
Career Start Year 2007
Number of shared co-authors 0
Hyunil Jo
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 2002
Number of shared co-authors 1
Rommie E Amaro
University of California
Career Start Year 2001
Number of shared co-authors 1
Matthew P Jacobson
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1999
Number of shared co-authors 7
Udupi A Ramagopal
Poornaprajna Institute of Scientific Research (PPISR)
Career Start Year 1998
Number of shared co-authors 1
Soumya S Ray
Lysosomal Therapeutics Inc.
Career Start Year 1997
Number of shared co-authors 1
Pavel Strop
Pfizer Inc.
Career Start Year 1997
Number of shared co-authors 2
Zihe Rao
Nankai University
Career Start Year 1995
Number of shared co-authors 1
Orly Dym
Weizmann Institute of Science
Career Start Year 1995
Number of shared co-authors 1
Shane Atwell
Lilly Research Laboratories
Career Start Year 1994
Number of shared co-authors 1
Alexander P Golovanov
The University of Manchester
Career Start Year 1991
Number of shared co-authors 2
Celia A Schiffer
University of Massachusetts Chan Medical School
Career Start Year 1990
Number of shared co-authors 1
Brian K Shoichet
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1989
Number of shared co-authors 12
Raymond C Stevens
iHuman Institute, ShanghaiTech University
Career Start Year 1988
Number of shared co-authors 2
Steven C Almo
Albert Einstein College of Medicine
Career Start Year 1988
Number of shared co-authors 2
David E Timm
Lilly Research Laboratories
Career Start Year 1988
Number of shared co-authors 1
Herman W T van Vlijmen
Leiden Academic Centre for Drug Research (LACDR), Leiden University
Career Start Year 1988
Number of shared co-authors 2
John M Louis
National Institute of Diabetes and Digestive and Kidney Diseases
Career Start Year 1988
Number of shared co-authors 1
Piotr Cieplak
Sanford-Burnham-Prebys Medical Discovery Institute
Career Start Year 1987
Number of shared co-authors 0
William F DeGrado
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1982
Number of shared co-authors 4
Ruben Abagyan
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1981
Number of shared co-authors 1
David I Stuart
University of Oxford
Career Start Year 1976
Number of shared co-authors 1
Ian A Wilson
The Scripps Research Institute, USA The Skaggs Institute for Chemical Biology
Career Start Year 1975
Number of shared co-authors 1
Charles L Brooks
University of Michigan ann arbor
Career Start Year 1974
Number of shared co-authors 1
James A Wells
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year 1974
Number of shared co-authors 5
Robert M Stroud
University of California San Francisco
Career Start Year 1965
Number of shared co-authors 6
Jens Meiler
Vanderbilt University
Career Start Year 1954
Number of shared co-authors 1

Collaborators

Charles S Craik
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 5
Priyadarshini Jaishankar
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 2
Adam R Renslo
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 2
Kathleen M Giacomini
University of California San Francisco
Co-authored papers 1
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers 1
Brian R Hearn
Department of Pharmaceutical Chemistry and, University of California san francisco
Co-authored papers 1
Hao Fan
College of Biotechnology and Bioengineering, Zhejiang University of Technology
Co-authored papers 1
Jean-Rene Galarneau
Preclinical Safety, Novartis Institutes for Biomedical Research
Co-authored papers 1
John J Irwin
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
Avner Schlessinger
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Michael C Thompson
University of California
Co-authored papers 1
Markus-Frederik Bohn
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 1
James S Fraser
University of California san francisco
Co-authored papers 1
Ethan G Geier
Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 1
Release 1.2